Literature DB >> 10676750

Recent advances in the diagnosis and treatment of central nervous system germ-cell tumours.

B S Hooda1, J L Finlay.   

Abstract

Primary germ-cell tumors of the central nervous system are rare neoplasms that are seen primarily in the pediatric age group. Because of their frequent location in the pituitary and suprasellar regions, they present with typical neuro-ophthalmologic and neuroendocrine symptoms. Sophisticated imaging and surgical biopsy allow precise anatomic definition, but only allow an approximate guess of the tumor histopathology. Tumor markers in the serum and cerebrospinal fluid are extremely helpful in the diagnosis and monitoring of response to treatment when they are detectable. Because of the deleterious effects of irradiation on neurocognitive and neuroendocrine functioning, we have looked at strategies that either reduce or eliminate radiation exposure. Large, randomized, prospective, cooperative trials in the future will be the only way to identify subgroups of patients that may benefit from particular treatment strategies.

Entities:  

Mesh:

Year:  1999        PMID: 10676750     DOI: 10.1097/00019052-199912000-00006

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  3 in total

1.  Rapidly growing giant suprasellar tumor in a high-risk child: treatment strategy and role of neuroendoscopic surgery in slit-like ventricles.

Authors:  Saad Hamdan Abdullah; Koreaki Irie; Shizuo Oi
Journal:  Childs Nerv Syst       Date:  2005-06-17       Impact factor: 1.475

Review 2.  Current advances in the diagnosis and management of intracranial germ cell tumors.

Authors:  Casilda Balmaceda; Jonathan Finlay
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

3.  Coexistence of intracranial germ cell tumor and craniopharyngioma in an adolescent: case report and review of the literature.

Authors:  Nikolaos Tsoukalas; Maria Tolia; Ioannis D Kostakis; Nikolaos Pistamaltzian; Dimitrios Tryfonopoulos; Georgios Lypas; Georgios Koumakis; Vasileios Barbounis; Nikolaos Goutas; Anna Efremidis
Journal:  Int J Clin Exp Med       Date:  2013-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.